Amgen (AMGN)

R&D to Revenue

18.58%

Quarterly · Period ending:

AMGN logo

AMGN R&D to Revenue

Latest reported18.58%
AMGN Quarterly R&D/Revenue (0.00% → 18.58%)
High-resolution chart · PNG

AMGN r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Amgen R&D to Revenue — Quarterly
Period endingR&D to Revenue
21.1614%
22.9259%
27.5447%
22.472%
23.3667%
24.5919%
27.2492%
24.4094%
24.6664%
26.2827%
26.2985%
24.4046%
23.7716%
25.8738%
27.8885%
29.5751%
23.9657%
26.2158%
24.6865%
23.4364%
22.036%
26.1881%
24.5885%
21.7795%
22.3921%
26.4269%
20.2625%
19.4935%
19.6858%
20.4893%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.